• Investor Information
    • Investor Information
    • Email Alerts
    • Share Price
    • Analyst Coverage
    • Announcements, Financial Reports & Filings
    • Corporate Governance
    • Shareholder Meetings
    • Summit Presentations
  • News
    • Press Releases
    • Congresses
  • Digital Library
  • Contact
  • Company
    • Mission Statement
    • About Us
    • Leadership
    • Board of Directors
    • Business Development
    • Contact Us
  • Pipeline
  • Ivonescimab (SMT112)*
    • Ivonescimab Overview
    • Akeso Partnership
    • Therapeutic Areas
  • Clinical Trials
    • Clinical Trials Overview
    • Harmoni Clinical Trial
    • Harmoni-3 Clinical Trial
    • Harmoni-7 Clinical Trial
    • IST Program
    • Early Access
  • Publications
  • Patients & Caregivers
    • Patients & Caregivers
    • HARMONi Clinical Trial
    • HARMONi-3 Clinical Trial
    • HARMONi-7 Clinical Trial
  • Careers
    • Careers Overview
    • Current Openings

Cookie Settings

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyse website traffic.

Strictly Necessary

Strictly necessary cookies are cookies necessary for the website to function and to respond to the user’s requests and actions. You can set your browser to block these cookies but when doing so, some parts of our websites will not be accessible or will not work.

Performance

Performance cookies enable to measure audience and performance on the website and help take into account the user’s choices.

Analytics

Analytics cookies are used to identify users’ preferences (visits, traffic, most popular pages or contents, etc.) and may be used to show relevant and targeted contents based on the users’ preferences and interests.

Back

Quick Links

  • About Summit Therapeutics
  • Investor Information
  • Ivonescimab (SMT112)*
  • Press Releases
  • Pipeline
  • Reports & Filings
  • Contact Us
  • Share Price

*Ivonescimab is an investigational therapy that is not presently approved by any regulatory authority other than China’s National Medical Products Administration (NMPA).

Follow us on Social Media

  • © 2025 Summit Therapeutics Inc.
  • Disclaimer
  • Privacy Notice
  • Online Terms of Use
  • Cookie Settings
  • © 2025 Summit Therapeutics Inc.

Trademarks, Registered or Otherwise, are the property of their respective owner(s).

You are leaving SMMTTX.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

Summit Therapeutics, Inc., is not responsible for the privacy notice of any third-party websites. We encourage you to read the privacy notice of every website you visit.

To stay on Summit’s website, click “Cancel” or click “Continue” to proceed.

Continue

Cookie Preferences

We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyse website traffic. By clicking 'Accept', you agree to our website's cookie use as described in our Privacy Notice. You can change your cookie settings at any time by clicking "Preferences".